Oxybutynin and Oedema peripheral - a phase IV clinical study of FDA data
Oedema peripheral is found among people who take Oxybutynin, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Oxybutynin and have Oedema peripheral. It is created by eHealthMe based on reports of 19,517 people who have side effects when taking Oxybutynin from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
19,517 people reported to have side effects when taking Oxybutynin.
Among them, 201 people (1.03%) have Oedema peripheral.
What is Oxybutynin?
Oxybutynin has active ingredients of oxybutynin. It is often used in urge incontinence. eHealthMe is studying from 19,743 Oxybutynin users for its effectiveness, alternative drugs and more.
What is Oedema peripheral?
Oedema peripheral (superficial swelling) is found to be associated with 3,433 drugs and 3,348 conditions by eHealthMe.
Number of Oxybutynin and Oedema peripheral reports submitted per year:
Time on Oxybutynin when people have Oedema peripheral *:
Gender of people who have Oedema peripheral when taking Oxybutynin*:
Age of people who have Oedema peripheral when taking Oxybutynin *:
Common drugs people take besides Oxybutynin *:
Common side effects people have besides Oedema peripheral *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Oxybutynin and have Oedema peripheral?Check whether Oedema peripheral is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Oedema peripheral and when was it recovered:
Expand to all the drugs that have ingredients of oxybutynin:
Alternative drugs to, pros and cons of Oxybutynin:
- Oxybutynin (19,743 reports)
Common Oxybutynin side effects:
- Fatigue (feeling of tiredness): 1,576 reports
- Drug ineffective: 1,529 reports
- Urinary tract infection: 1,145 reports
- Weakness: 1,129 reports
- Diarrhea: 1,044 reports
- Pain: 963 reports
- Dizziness: 944 reports
Browse all side effects of Oxybutynin:a b c d e f g h i j k l m n o p q r s t u v w x y z
Oedema peripheral treatments and more:
- Oedema peripheral (158,982 reports)
COVID vaccines that are related to Oedema peripheral:
- Oedema peripheral in Moderna COVID Vaccine
- Oedema peripheral in Pfizer BioNTech Covid Vaccine
- Oedema peripheral in Johnson and Johnson Covid Vaccine
Common drugs associated with Oedema peripheral:
- Aspirin: 9,679 reports
- Prednisone: 9,651 reports
- Lasix: 9,060 reports
- Furosemide: 8,501 reports
- Enbrel: 6,208 reports
- Methotrexate: 5,868 reports
- Humira: 5,853 reports
- Amlodipine: 5,576 reports
- Lyrica: 5,499 reports
- Metformin: 5,066 reports
All the drugs that are associated with Oedema peripheral:
- Oedema peripheral (3,433 drugs)
Common conditions associated with Oedema peripheral:
- High blood pressure: 10,813 reports
- Rheumatoid arthritis: 9,825 reports
- Primary pulmonary hypertension: 7,964 reports
- Pain: 6,039 reports
- Osteoporosis: 4,965 reports
All the conditions that are associated with Oedema peripheral:
- Oedema peripheral (3,348 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on oxybutynin (the active ingredients of Oxybutynin) and Oxybutynin (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Cardura and Injection Site Pain - a second ago
- Toradol and Pelvic Infection - a second ago
- Benzonatate and Pruritus Allergic - 5 seconds ago
- Divalproex Sodium and Alcoholism - 12 seconds ago
- Morphine Sulfate and Systemic Sclerosis (Scleroderma) - 13 seconds ago
- Praluent and Rivaroxaban drug interaction - 18 seconds ago
- Arixtra and Oedema Peripheral - 18 seconds ago
- Lunesta and Paraplatin drug interaction - 19 seconds ago
- Cholestyramine and Diverticular Perforation - 21 seconds ago
- Psyllium and Oedema Peripheral - 23 seconds ago